Physician

Felix O Sogade, M.D.

According to 2025 Medicare claims, Felix Sogade, M.D. (NPI: 1992889505) practices cardiac electrophysiology in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is MACON ELECTROPHYSIOLOGY ASSOCIATES (NPI: 1306923495; TIN: 582375271) and primary practice location at 31201-6889. Sogade is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Sogade's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,350 traditional Medicare patients, billed 9,553 HCPCS/CPT codes, and received $429,888 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,245 prescription claims across 1,152 beneficiaries totaling $3,667,180 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 12 claims. Open Payments data shows 95 records totaling $136,080. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $579,438 to $429,888. In contrast, Part D prescription costs have moved sharply higher in recent years, from $721,286 to $3,667,180. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,019	11,106	$579,438
2016	2,139	13,463	$606,992
2017	2,260	15,197	$682,234
2018	2,650	16,884	$683,676
2019	2,565	17,074	$677,908
2020	2,377	14,579	$555,201
2021	2,037	13,258	$566,045
2022	1,646	11,221	$500,618
2023	1,344	10,419	$463,425
2024	1,350	9,553	$429,888

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	817	8,286	$721,286
2016	843	8,342	$840,345
2017	959	8,979	$1,076,656
2018	1,005	8,860	$1,268,694
2019	1,036	8,663	$1,583,812
2020	1,017	7,981	$1,765,189
2021	1,101	7,757	$2,351,771
2022	1,224	8,959	$2,669,381
2023	1,156	9,055	$3,236,531
2024	1,152	9,245	$3,667,180

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$1,062
2017	N/R	12	$613
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$24,038
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	288	400	$91
93297	Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days	366	1,124	$38
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	340	1,040	$24
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	463	1,415	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	792	2,448	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	965	47,550	$917,093
Xarelto	Rivaroxaban	650	31,551	$581,972
Onpattro	Patisiran Sodium,lipid Complex	11	231	$439,147
Farxiga	Dapagliflozin Propanediol	302	13,345	$247,621
Entresto	Sacubitril/Valsartan	238	10,739	$241,579

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$27,382	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$108,699	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Felix O. Sogade, M.D.?

Tedicare shows public-source Medicare data for Felix O. Sogade, M.D. (NPI 1992889505), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Felix O. Sogade, M.D. have ACO affiliation data?

Felix O. Sogade, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Felix O. Sogade, M.D.?

Felix O. Sogade, M.D. is linked to MACON ELECTROPHYSIOLOGY ASSOCIATES (billing NPI 1306923495) in the available physician profile data.

Does Felix O. Sogade, M.D. have Open Payments data?

Felix O. Sogade, M.D. has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.